Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Pediatrics|December 10, 1999
Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infantsK L Watterberg, J S Gerdes, K L Gifford, et al.
Pediatrics|December 1, 1983
Decreased plasma fibronectin in neonatal sepsisJ S Gerdes, M C Yoder, S D Douglas, et al.
Journal of Neurosurgery|August 1, 1997
Effects of serotonin on cerebral circulation after middle cerebral artery occlusionM G Muhonen, S C Robertson, J S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 16, 2019
Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseasesM Augustin, U Mrowietz, C Luck-Sikorski, et al.
The Journal of Dermatological Treatment|May 18, 2005
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasisP Reygagne, U Mrowietz, J Decroix, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2018
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)R Bissonnette, T Luger, D Thaçi, et al.
The British Journal of Dermatology|December 1, 1993
Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre studyH H Henneicke-von Zepelin, U Mrowietz, L Färber, et al.
American Journal of Obstetrics and Gynecology|October 4, 2003
Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort studySoraya Abbasi, Jeffrey S Gerdes, Harish M Sehdev, et al.
Frontiers in Medicine|February 9, 2026
Case Report: Dupilumab in difficult-to-treat bullous pemphigoid at the University Hospital Schleswig-Holstein, Campus KielY Mehrjerdian, R Atallah, B Wijaya, et al.
Archives of Dermatological Research|June 11, 2013
Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional studyA Nast, U Mrowietz, K Kragballe, et al.
Pageof 23